What this means
This study has not started recruiting people yet, so no results exist. It plans to check whether a short screening score predicts frailty and early death in older cancer patients.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 70 and over · 250 adults aged 70 or older with new solid tumors in Brazil
- Where
- 1 site
The science
- Registered title
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in Brazil
- Trial ID
- NCT07773285 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Solid Tumor, Metastatic Solid Tumor, Recurrent Solid Tumor
- Sponsor
- Latin American Cooperative Oncology Group
- Ages
- 70 Years to no maximum
- Dates
- First posted Aug 19, 2026 · updated Aug 26, 2026
Registry summary
This is a prospective observational cohort study including 250 individuals aged 70 years or older newly diagnosed with solid tumors. In this non-interventional study, all patient contacts will be conducted via telephone or video call.
After obtaining informed consent which will be conducted electronically, an initial telemedicine assessment will be performed. During this evaluation, sociodemographic and clinical data will be collected, and a Comprehensive Geriatric Assessment (CGA) will be conducted. The assessment will be performed by a trained professional using internationally recognized, validated instruments that are preferably culturally adapted to the Brazilian population. The G8 score will be calculated based on information collected at baseline. Additionally, medication use, the Charlson Comorbidity Index, Mini Nutritional Assessment, and self-rated health status will be recorded. The total G8 score ranges from 0 to 17, with higher scores indicating better health status (abnormal G8 score ≤14).
Sites (1)
- HCOR - Hospital do Coração, São Paulo, São Paulo, Brazil